MedTrace Logo

Intensive Care Anxiety in SARS-CoV-2 Patients

NCT04715477 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-01-20

No results posted yet for this study

Summary

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Conditions

Interventions

BEHAVIORAL

Hospital Anxiety Depression Measure

Hospital Anxiety Depression Measure

Sponsors & Collaborators

  • Derince Training and Research Hospital

    lead OTHER

Principal Investigators

  • ilke kupeli · Derince Training and Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-17
Primary Completion
2021-04-01
Completion
2021-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04715477 on ClinicalTrials.gov